Joe Moore Award
Story Poster
Around CFB: Ags must see 'Moore' from the Maroon Goons at Mizzou
9 mo ago by Olin Buchanan
Texas A&M's offensive line is among the nation's elite, and the "Maroon Goons" are making a strong case to win the Joe Moore Award this season. As the Aggies prepare to face Missouri's stout pass rush, more should be expected from A&M's offensive front if they are to win the Moore.
Story Poster
Maroon Goons aim for Moore as fall camp in Aggieland closes
1 yr ago by Olin Buchanan
Texas A&M’s offensive line has earned a lot of respect after its performance in 2024. Now, the Aggies' goals include the SEC Championship, a national championship and the Joe Moore Award, which is presented annually to the nation’s premier college offensive line.
Story Poster
17:48
Phil Steele provides in-depth analysis on A&M's 2025 opponents
1 yr ago by David Nuño
One of the most well-known college football analysts in the country, Phil Steele joined TexAgs Live on Thursday morning to share his scouting report on Texas A&M and the Aggies' opponents this season. Steele discussed his thoughts on Mike Elko and much more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
NFL Draft picks among key statistical indicators of success in the SEC
1 yr ago by Luke Evangelist
Talking season is officially over as the Aggies head into Mike Elko's second year at A&M. Six players are back who could have been NFL Draft picks in April, and roster stability is one of the few indicators that suggest A&M could again push for an SEC Championship Game berth.
Story Poster
14:09
SEC Network's Cole Cubelic details significance of the Joe Moore Award
4 yr ago by Richard Zane
During Thursday's edition of TexAgs Radio, ESPN & SEC Network analyst Cole Cubelic joined the show to share his thoughts on the latest news & notes from around college football and discuss the significance of the Joe Moore Award.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.